|
|
Volumn 21, Issue 23, 2003, Pages 4261-4262
|
|
Bisphosphonates for men with prostate cancer: Sifting through the rubble
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
PAMIDRONIC ACID;
PLACEBO;
ZOLEDRONIC ACID;
ANTINEOPLASTIC AGENT;
BONE METASTASIS;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER PAIN;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DIZZINESS;
EDITORIAL;
FATIGUE;
FEVER;
HUMAN;
MYALGIA;
NAUSEA;
PAIN ASSESSMENT;
PRIORITY JOURNAL;
PROSTATE CANCER;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
WEIGHT REDUCTION;
BONE TUMOR;
DOUBLE BLIND PROCEDURE;
MALE;
METASTASIS;
NOTE;
PAIN;
PALLIATIVE THERAPY;
PATHOLOGY;
PROSTATE TUMOR;
ANTINEOPLASTIC AGENTS;
BONE NEOPLASMS;
DIPHOSPHONATES;
DOUBLE-BLIND METHOD;
HUMANS;
MALE;
PAIN;
PALLIATIVE CARE;
PROSTATIC NEOPLASMS;
|
|
EID: 0642337992
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2003.07.078 Document Type: Editorial |
|
Times cited : (8)
|
|
References (7)
|
